A breakthrough drug reduces the rate of serious asthma attacks by around two-thirds, new research suggests.
The new injectable medication has been hailed as the most ‘promising’ hope for patients with persistent, uncontrolled symptoms.
A trial found those on tezepelumab had 61 percent to 71 percent fewer exacerbations that needed a hospital visit or change in medication dose compared with those who took a placebo.
Tezepelumab is a biological therapy, which work by stimulating the body’s immune system to defend itself.
If approved, the drug could join a group of costly medications that appear to help when nothing else offers relief in severe cases.